These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Multifocal alopecia areata during systemic cyclosporine A therapy. Cerottini JP; Panizzon RG; de Viragh PA Dermatology; 1999; 198(4):415-7. PubMed ID: 10490301 [No Abstract] [Full Text] [Related]
4. Partial response of severe alopecia areata to cyclosporine A. Ferrando J; Grimalt R Dermatology; 1999; 199(1):67-9. PubMed ID: 10449964 [No Abstract] [Full Text] [Related]
5. Cyclosporine as a cause of unilateral gynecomastia in renal transplant recipient. Kumar A; Bansal V; Mehra S; Minz M; Sharma AK J Assoc Physicians India; 1999 Jul; 47(7):746. PubMed ID: 10778606 [No Abstract] [Full Text] [Related]
7. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center. Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271 [No Abstract] [Full Text] [Related]
8. Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction. Bakr MA; Refaie A; Mekresh M; Ihab MH; Sobh M; Ghoneim MA Transplant Proc; 1997 Nov; 29(7):2939-40. PubMed ID: 9365621 [No Abstract] [Full Text] [Related]
9. Occurrence of alopecia areata in a patient receiving systemic cyclosporine A. Misciali C; Peluso AM; Cameli N; Tosti A Arch Dermatol; 1996 Jul; 132(7):843-4. PubMed ID: 8678589 [No Abstract] [Full Text] [Related]
10. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients. Gracida C; Melchor JL Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318 [No Abstract] [Full Text] [Related]
11. Oral administration of cyclosporin A in patients with severe alopecia areata. Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A Int J Tissue React; 2005; 27(3):107-10. PubMed ID: 16372476 [TBL] [Abstract][Full Text] [Related]
12. Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353. Pescovitz MD Transplant Proc; 1996 Aug; 28(4):2196-8. PubMed ID: 8769198 [No Abstract] [Full Text] [Related]
13. A randomized, controlled trial to assess the safety of switching stable renal transplant patients from Sandimmun to Sandimmun Neoral. Loo CS; Morad Z; Lim TO; Fan KS; Suleiman AB Transplant Proc; 1996 Jun; 28(3):1328-9. PubMed ID: 8658680 [No Abstract] [Full Text] [Related]
15. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients. Gracida C; Melchor JL; Miranda ME; Bartolano C Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191 [No Abstract] [Full Text] [Related]
16. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. Shapiro J; Lui H; Tron V; Ho V J Am Acad Dermatol; 1997 Jan; 36(1):114-7. PubMed ID: 8996277 [No Abstract] [Full Text] [Related]
17. Two cases of tacrolimus-induced alopecia following kidney transplantation. Ushigome H; Yoshimura N; Okamoto M; Najima H; Hamajima T; Nakai I; Oka T Transplant Proc; 1999 Nov; 31(7):2885-6. PubMed ID: 10578326 [No Abstract] [Full Text] [Related]
18. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population. Griffin PJ; Moore RH; Jurewicz WA; Lord RH; Webley Y; Jenkins J Transplant Proc; 1997; 29(1-2):303. PubMed ID: 9123007 [No Abstract] [Full Text] [Related]
19. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine. Okechuku G; Boulos AK; Herman L; Upadhyay K Pediatr Transplant; 2015 May; 19(3):E78-82. PubMed ID: 25661468 [TBL] [Abstract][Full Text] [Related]
20. Sever lower gastro-intestinal bleeding by CMV in a kidney transplant with low-dose immunosuppression. Ríos A; Ruiz J; Rodríguez JM; Parrilla P Nefrologia; 2016; 36(4):454-5. PubMed ID: 26873549 [No Abstract] [Full Text] [Related] [Next] [New Search]